Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-25-007780
Filing Date
2025-05-14
Accepted
2025-05-14 17:06:46
Documents
61
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q glyc-20250331x10q.htm   iXBRL 10-Q 714033
2 EX-31.1 glyc-20250331xex31d1.htm EX-31.1 17010
3 EX-32.1 glyc-20250331xex32d1.htm EX-32.1 8302
  Complete submission text file 0001558370-25-007780.txt   3914250

Data Files

Seq Description Document Type Size
4 EX-101.SCH glyc-20250331.xsd EX-101.SCH 33684
5 EX-101.CAL glyc-20250331_cal.xml EX-101.CAL 26770
6 EX-101.DEF glyc-20250331_def.xml EX-101.DEF 153336
7 EX-101.LAB glyc-20250331_lab.xml EX-101.LAB 302347
8 EX-101.PRE glyc-20250331_pre.xml EX-101.PRE 261989
64 EXTRACTED XBRL INSTANCE DOCUMENT glyc-20250331x10q_htm.xml XML 492313
Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36177 | Film No.: 25946971
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)